滴氨酸对运动行为和血管功能的影响:对体育领域的可能影响
Jazmín Flores-Monroy1, Diana Ramírez-Hernández1, Diego Lezama-Martínez1
1Laboratorio de Farmacología del Miocardio, Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Cuautitlán Izcalli, Estado de México, Mexico.
Drug testing and analysis
|March 6, 2025
概括
丁氨酸 (DMH) 可能具有运动和身体刺激作用,与其已知的镇静性相反. 在DMH配方中的西奥菲林 (8-Cl-T) 负责增加血压和心率.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 心血管研究研究心血管研究
背景情况:
- 丁氨酸 (DMH) 对精神运动功能表现出不同的影响,一些研究报告了镇静作用,另一些研究报告了刺激作用.
- 众所周知,第一代抗组胺药物会损害认知,精神运动和驾驶性能.
- 研究DMH的潜在刺激作用对于了解它对身体活动和认知功能的影响至关重要.
研究的目的:
- 用动物模型确定二甲酸盐 (DMH) 对身体活动,认知功能和心血管参数的潜在刺激作用.
- 确定DMH中负责任何观察到的刺激作用的特定成分.
主要方法:
- 两阶段研究涉及用载体,莫达菲尼尔,DMH,二水胺 (DPH),8-甲 (8-Cl-T) 和神 (TEO) 治疗的动物模型.
- 评估运动协调,平衡,身体活动,血液动力学和氧化 (NO) 水平.
- 量化葡萄糖,胰岛素,行为分析,血压和血管对烯和乙胆的反应.
主要成果:
- DMH显示出潜在的运动和身体刺激作用,并增加了肺 NO 水平.
- 迪芬胺 (DPH) 诱导了强迫性行为,由8-Cl-T减少了这种行为.
- DMH降低了血管对烯和乙胆的反应性,而8-Cl-T被确定为增加血压和心率的成分.
结论:
- DMH可能具有双重效应,可能改善运动和身体活动,同时也影响心血管参数.
- 8-甲 (8-Cl-T) 是DMH的一种成分,是导致血压和心率上升的原因.
- 需要进一步的研究来阐明DMH及其单个成分的复杂药理特征.
相关概念视频
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
232
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
232
Cholinergic Antagonists: Pharmacological Actions
751
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
751
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.2K
Antihypertensive Drugs: Vasodilators
455
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
455
Cholinergic Antagonists: Therapeutic Uses
699
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
699
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
521
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
521


